Evidence map›Paper›PMID 34830828›Full record

ArticleCancers2021

Development of a Radiomic-Based Model Predicting Lymph Node Involvement in Prostate Cancer Patients.

Vincent Bourbonne, Vincent Jaouen, Truong An Nguyen, Valentin Tissot, Laurent Doucet, Mathieu Hatt, Dimitris Visvikis, Olivier Pradier, Antoine Valéri, Georges Fournier and 1 more

Abstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Vincent BourbonneRadiation Oncology Department, University Hospital, 29200 Brest, France.ORCID 0000-0002-2631-0029
Vincent JaouenLaTIM, UMR 1101, INSERM, University Brest, 29200 Brest, France.ORCID 0000-0003-4498-5713
Truong An NguyenLaTIM, UMR 1101, INSERM, University Brest, 29200 Brest, France.ORCID 0000-0002-7373-1635
Valentin TissotRadiology Department, University Hospital, 29200 Brest, France.
Laurent DoucetPathology Department, University Hospital, 29200 Brest, France.
Mathieu HattLaTIM, UMR 1101, INSERM, University Brest, 29200 Brest, France.
Dimitris VisvikisLaTIM, UMR 1101, INSERM, University Brest, 29200 Brest, France.
Olivier PradierRadiation Oncology Department, University Hospital, 29200 Brest, France.
Antoine ValériLaTIM, UMR 1101, INSERM, University Brest, 29200 Brest, France.
Georges FournierLaTIM, UMR 1101, INSERM, University Brest, 29200 Brest, France.
Ulrike SchickRadiation Oncology Department, University Hospital, 29200 Brest, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Significant advances in lymph node involvement (LNI) risk modeling in prostate cancer (PCa) have been achieved with the addition of visual interpretation of magnetic resonance imaging (MRI) data, but it is likely that quantitative analysis could further improve prediction models. In this study, we aimed to develop and internally validate a novel LNI risk prediction model based on radiomic features extracted from preoperative multimodal MRI. All patients who underwent a preoperative MRI and radical prostatectomy with extensive lymph node dissection were retrospectively included in a single institution. Patients were randomly divided into the training (60%) and testing (40%) sets. Radiomic features were extracted from the index tumor volumes, delineated on the apparent diffusion coefficient corrected map and the T2 sequences. A ComBat harmonization method was applied to account for inter-site heterogeneity. A prediction model was trained using a neural network approach (Multilayer Perceptron Network, SPSS v24.0©) combining clinical, radiomic and all features. It was then evaluated on the testing set and compared to the current available models using the Receiver Operative Characteristics and the C-Index. Two hundred and eighty patients were included, with a median age of 65.2 y (45.3-79.6), a mean PSA level of 9.5 ng/mL (1.04-63.0) and 79.6% of ISUP ≥ 2 tumors. LNI occurred in 51 patients (18.2%), with a median number of extracted nodes of 15 (10-19). In the testing set, with their respective cutoffs applied, the Partin, Roach, Yale, MSKCC, Briganti 2012 and 2017 models resulted in a C-Index of 0.71, 0.66, 0.55, 0.67, 0.65 and 0.73, respectively, while our proposed combined model resulted in a C-Index of 0.89 in the testing set. Radiomic features extracted from the preoperative MRI scans and combined with clinical features through a neural network seem to provide added predictive performance compared to state of the art models regarding LNI risk prediction in PCa.

Indexed as

lymph node involvementMRIpredictionprostate cancerradiomics

Identifiers

PMID34830828
PMCPMC8616049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.